Supernus Pharmaceuticals DSO Ratio 2011-2026 | SUPN

Annual DSO Ratio Supernus Pharmaceuticals

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
78.9	93	86	91.2	80	81.2	91.9	79.2	70.5	65.5	51.6	168	166	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
168	51.6	92.6

Quarterly DSO Ratio Supernus Pharmaceuticals

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
74.1	79	87.6	-	77.4	81.4	92.7	-	82.5	94.3	91.7	-	82.9	81.3	88	-	83.3	85.3	93.4	-	82.9	101	110	79.3	78	76.1	102	81	91.2	94.3	85	67.7	74.4	78.9	84.9	60.8	66.7	73.4	69.6	54.1	60.1	66.3	68.5	50.5	70.2	57.1	113	44.6	367	1.64 K	1.57 K	21.4	251	-	28.1	139	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
1.64 K	21.4	149

DSO Ratio of other stocks in the Biotechnology industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
Adverum Biotechnologies ADVM	222	-	-	$ 86.2 M	USA
AgeX Therapeutics AGE	78.4	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
I-Mab IMAB	271	-	-	$ 866 M	China
Aptorum Group Limited APM	20.6	$ 0.81	0.15 %	$ 4.42 M	China
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
Ascendis Pharma A/S ASND	132	$ 234.52	-0.2 %	$ 5 B	Danmark
Albireo Pharma ALBO	14.7	-	-0.23 %	$ 916 M	USA
Alterity Therapeutics Limited ATHE	16.2 K	$ 3.44	3.42 %	$ 8.28 B	Australia
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	204	-	-18.52 %	$ 27.3 M	Britain
BioMarin Pharmaceutical BMRN	82.8	$ 61.58	-1.66 %	$ 11.7 B	USA
Acorda Therapeutics ACOR	48.3	-	-24.86 %	$ 820 K	USA
Aravive ARAV	16.8	-	-13.39 %	$ 1.45 M	USA
Applied Genetic Technologies Corporation AGTC	0.114	-	-	$ 26.5 M	USA
Capricor Therapeutics CAPR	31.9	$ 28.24	1.18 %	$ 756 M	USA
Axsome Therapeutics AXSM	105	$ 165.14	-2.83 %	$ 8.22 B	USA
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
CASI Pharmaceuticals CASI	87.4	$ 0.31	-61.59 %	$ 42.2 M	USA
Alpine Immune Sciences ALPN	154	-	-	$ 2.17 B	USA
BioDelivery Sciences International BDSI	115	-	-4.8 %	$ 255 M	USA
Catalyst Biosciences CBIO	3.24	$ 12.21	-3.48 %	$ 804 M	USA
Aeterna Zentaris AEZS	146	-	5.93 %	$ 314 M	Canada
BeiGene, Ltd. BGNE	49.5	-	0.49 %	$ 251 B	Cayman-islands
Biogen BIIB	50.7	$ 191.78	-1.72 %	$ 28.1 B	USA
Bellicum Pharmaceuticals BLCM	6.09	-	-9.72 %	$ 5.89 M	USA
Baudax Bio BXRX	126	-	0.59 %	$ 63 K	USA
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
Aridis Pharmaceuticals ARDS	59	-	17.91 %	$ 11.1 M	USA
Amneal Pharmaceuticals AMRX	55.7	$ 14.64	-0.17 %	$ 4.52 B	USA